Cargando…
ADAMTS13: An Emerging Target in Stroke Therapy
Thrombosis is the predominant underlying mechanism of acute ischemic stroke (AIS). Though thrombolysis with tPA has been proven to be effective in treating AIS within the time window, the majority of AIS patients fail to receive tPA due to various reasons. Current medical therapies for AIS have limi...
Autores principales: | Chen, Xin, Cheng, Xin, Zhang, Shufan, Wu, Danhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650536/ https://www.ncbi.nlm.nih.gov/pubmed/31379722 http://dx.doi.org/10.3389/fneur.2019.00772 |
Ejemplares similares
-
The Value of ADAMTS13 in Predicting Clinical Outcomes in Patients With Acute Ischemic Stroke Receiving Thrombolysis
por: Su, Ya, et al.
Publicado: (2020) -
ADAMTS-13 activity in stroke of known and unknown cause: Relation to vascular risk factor burden
por: Grosse, Gerrit M., et al.
Publicado: (2023) -
The Relationship Between ADAMTS13 Activity and Overall Cerebral Small Vessel Disease Burden: A Cross-Sectional Study Based on CSVD
por: Sun, Wenbo, et al.
Publicado: (2021) -
Impact of Jilin Province Stroke Emergency Maps on Acute Stroke Care Improvement in Northeast China
por: Jin, Hang, et al.
Publicado: (2020) -
ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Bonnez, Quintijn, et al.
Publicado: (2023)